Literature DB >> 8618188

Colonization with antibiotic-resistant Streptococcus pneumoniae in children with sickle cell disease.

R W Steele1, R Warrier, P J Unkel, B J Foch, R F Howes, S Shah, K Williams, S Moore, S J Jue.   

Abstract

OBJECTIVE: Because of susceptibility to severe pneumococcal infection, children with sickle cell disease (SCD) routinely receive penicillin prophylaxis. Increasing rates of penicillin resistance have been reported throughout the world. Our objective was to assess the prevalence of nasopharyngeal colonization with Streptococcus pneumoniae and to assess the antimicrobial susceptibility of the organisms in children with SCD. STUDY
DESIGN: Nasopharyngeal cultures for S. pneumoniae were obtained from all children with SCD attending clinics in a statewide university-based network. Background colonization rates were determined in children attending day care centers in some of the same locations. All recovered S. pneumoniae organisms were tested for susceptibility to penicillin, and all resistant strains were examined for susceptibility to other antibiotics.
RESULTS: Overall nasopharyngeal pneumococcal colonization rates among children with SCD were 12%. Colonization was associated with age less than 2 years (p <0.001) and day care attendance for more than 20 hr/wk (p = 0.00005). More than half of these strains (62%) were resistant to penicillin, 33% having intermediate resistance (minimal inhibitory concentration 0.06 to 1 microgram/ml) and 29%, high level resistance (minimal inhibitory concentration > or = 2.0 microgram/ml). Penicillin resistance was associated with penicillin prophylaxis (p <0.01). Many of these organisms were also resistant to other classes of antibiotics.
CONCLUSIONS: Although penicillin prophylaxis and pneumococcal vaccine for patients with SCD have reduced overall nasopharyngeal colonization and disease caused by S. pneumoniae (p <0.001), a higher percentage of colonizing strains are now resistant both to penicillin and to other antimicrobial agents (p <0.01). Newer strategies for preventing disease and early management of suspected pneumococcal infection in these children must be developed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8618188     DOI: 10.1016/s0022-3476(96)70365-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  12 in total

1.  Influence of patient age on Streptococcus pneumoniae serotypes causing invasive disease.

Authors:  J Inostroza; A M Vinet; G Retamal; P Lorca; G Ossa; R R Facklam; R U Sorensen
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

2.  Penicillin prophylaxis in children with sickle cell disease.

Authors:  Mary Petrea Cober; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2010-07

3.  Risk Factors for Pneumococcal Colonization of the Nasopharynx in Alaska Native Adults and Children.

Authors:  Jonathan Reisman; Karen Rudolph; Dana Bruden; Debby Hurlburt; Michael G Bruce; Thomas Hennessy
Journal:  J Pediatric Infect Dis Soc       Date:  2013-11-13       Impact factor: 3.164

4.  Trovafloxacin, a new fluoroquinolone with potent activity against Streptococcus pneumoniae.

Authors:  K S Thomson; S A Chartrand; C C Sanders; S L Block
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

5.  Capsular serotype and antibiotic resistance of Streptococcus pneumoniae isolates in two Chilean cities.

Authors:  J Inostroza; O Trucco; V Prado; A M Vinet; G Retamal; G Ossa; R R Facklam; R U Sorensen
Journal:  Clin Diagn Lab Immunol       Date:  1998-03

6.  Ten-year surveillance of pneumococcal infections in Temuco, Chile: implications for vaccination strategies.

Authors:  Jaime Inostroza; Vijna Illesca; Patricia Reydet; Ana Maria Vinet; Gonzalo Ossa; Sergio Muñoz; Terry Thompson; Ricardo U Sorensen
Journal:  Clin Vaccine Immunol       Date:  2007-03-28

7.  Genomic analyses of pneumococci from children with sickle cell disease expose host-specific bacterial adaptations and deficits in current interventions.

Authors:  Robert Carter; Joshua Wolf; Tim van Opijnen; Patricia M Flynn; Elaine I Tuomanen; Jason W Rosch; Martha Muller; Caroline Obert; Corinna Burnham; Beth Mann; Yimei Li; Randall T Hayden; Tamara Pestina; Derek Persons; Andrew Camilli
Journal:  Cell Host Microbe       Date:  2014-05-14       Impact factor: 21.023

8.  Relationship between antibiotic resistance and sickle cell anemia: preliminary evidence from a pediatric carriage study in Ghana.

Authors:  Eric S Donkor; Ebenezer Foster-Nyarko; Christabel C Enweronu-Laryea
Journal:  Infect Drug Resist       Date:  2013-07-29       Impact factor: 4.003

9.  Cephalosporin-resistant pneumococci and sickle cell disease.

Authors:  Martha L Miller; Caroline A Obert; Geli Gao; Najat C Daw; Patricia Flynn; Elaine Tuomanen
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883

10.  Guidelines on the treatment of primary immune thrombocytopenia in children and adolescents: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2012.

Authors:  Sandra Regina Loggetto; Josefina Aparecida Pellegrini Braga; Mônica Pinheiro de Almeida Veríssimo; Wanderley Marques Bernardo; Leticia Medeiros; Andrea Thives de Carvalho Hoepers
Journal:  Rev Bras Hematol Hemoter       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.